Literature DB >> 1742020

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

H S Phillips1, J M Hains, M Armanini, G R Laramee, S A Johnson, J W Winslow.   

Abstract

In recent years, nerve growth factor (NGF) has gained attention as a potential therapeutic agent for Alzheimer's disease (AD). To study the expression of NGF and its homologs, brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), postmortem samples of hippocampus from AD and control donors were examined by in situ hybridization. Hybridization signal for BDNF, but not NGF or NT-3, was decreased in samples of hippocampus from donors with AD. Decreased transcript abundance of BDNF mRNA in hippocampi of individuals with AD was verified by an RNAase protection assay. These results suggest the possibility that decreased expression of BDNF may contribute to the progression of cell death in AD.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1742020     DOI： 10.1016/0896-6273(91)90273-3

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  279 in total

Review 1.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

2.  Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons.

Authors:  Liqi Tong; Robert Balazs; Phillip L Thornton; Carl W Cotman
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

Review 3.  Metabolic reserve as a determinant of cognitive aging.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

Review 5.  Progesterone, brain-derived neurotrophic factor and neuroprotection.

Authors:  M Singh; C Su
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

6.  Localization of BDNF expression in the developing brain of zebrafish.

Authors:  E De Felice; I Porreca; E Alleva; P De Girolamo; C Ambrosino; E Ciriaco; A Germanà; P Sordino
Journal:  J Anat       Date:  2014-03-04       Impact factor: 2.610

Review 7.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

9.  Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease.

Authors:  T Leyhe; Elke Stransky; G W Eschweiler; G Buchkremer; C Laske
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

10.  Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor.

Authors:  F Sohrabji; R C Miranda; C D Toran-Allerand
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.